Concepedia

Matthew Aldridge

MA

13

Publications

587

Citations

11

H-Index

1961

Active since

Affiliations

University College London(Current)

University College London Hospitals NHS Foundation Trust

University College Hospital

University of Oxford

Matthew Aldridge is an author at University College London specializing in medicine, radiation oncology, and oncology.

Top concepts

Publications per year

1961–2022

13

Publications

13

<sup>177</sup>Lu-DOTATATE Molecular Radiotherapy for Childhood Neuroblastoma

J. Gains, Jamshed Bomanji, Naomi Fersht et al. · Journal of Nuclear Medicine · 2011 · 160 citations · Full text

<sup>18</sup>F-FDG PET/CT and <sup>123</sup>I-Metaiodobenzylguanidine Imaging in High-Risk Neuroblastoma: Diagnostic Comparison and Survival Analysis

Mark N. Gaze, Kevin P. Sullivan, Matthew Aldridge et al. · Journal of Nuclear Medicine · 2011 · 96 citations

Peptide receptor radionuclide therapy for aggressive atypical pituitary adenoma/carcinoma: variable clinical response in preliminary evaluation

Jillian Maclean, Matthew Aldridge, Jamshed Bomanji et al. · Pituitary · 2013 · 69 citations

, , +10

68Ga-DOTATATE and 123I-mIBG as imaging biomarkers of disease localisation in metastatic neuroblastoma: implications for molecular radiotherapy

J. Gains, Matthew Aldridge, Maria Vittoria Mattoli et al. · Nuclear Medicine Communications · 2020 · 48 citations

A phase IIa trial of molecular radiotherapy with 177-lutetium DOTATATE in children with primary refractory or relapsed high-risk neuroblastoma

J. Gains, V. V. Moroz, Matthew Aldridge et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2020 · 46 citations

, , +10

Rows per page

1–5 of 13